Aucamp M, Liebenberg W, Okaecwe T, Geldenhuys M, Stieger N
Pharmazie. 2019 Jun 1;74(6):350-351. doi: 10.1691/ph.2019.8189.
Previous isothermal microcalorimetry studies at 40 °C, with and without humidity (RH 75%), had shown no incompatibility between rifampicin (RIF), isoniazid (INH), pyrazinamide (PZA) and ethambutol HCl (EMB). The purpose of this study was to explore any interactions at an increased temperature of 50 °C and also to investigate the possibility of incompatibilities between the drugs and tablet excipients used in the most commonly prescribed commercial four-drug TB FDC. No incompatibilities were observed between the excipients, or when the excipients were tested with the four drugs individually. Incompatibility was observed with the four drugs combined.
先前在40°C、有湿度(相对湿度75%)和无湿度条件下进行的等温微量热法研究表明,利福平(RIF)、异烟肼(INH)、吡嗪酰胺(PZA)和盐酸乙胺丁醇(EMB)之间不存在不相容性。本研究的目的是探索在50°C的升高温度下是否存在任何相互作用,同时研究最常用的商业化四联抗结核固定剂量复方制剂中使用的药物与片剂辅料之间发生不相容性的可能性。在辅料之间未观察到不相容性,或者当辅料分别与四种药物进行测试时也未观察到不相容性。但四种药物组合时观察到了不相容性。